Dr. Fred James Crapse Jr., D.O. Surgery Medicare: May Accept Medicare Assignments Practice Location: 519 N Main St, Bristow, OK 74010 Phone: 918-701-2365 Fax: 918-367-5272 |
News Archive
Some people who experienced a 'mild' infection of Covid-19 are suffering long-lasting symptoms months after contracting the virus,known as 'long Covid'.
White men who exercise at high levels are 86 percent more likely than people who exercise at low levels to experience a buildup of plaque in the heart arteries by middle age, a new study suggests.
Intarcia Therapeutics, Inc. presented today the results of a phase 2 clinical study of ITCA 650 (DUROSĀ® continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual Conference of the American Diabetes Association in Orlando, FL (June 25-29, 2010). Results of the phase 2 study demonstrated substantial reductions in HbA1c and body weight during the 12 weeks of treatment with ITCA 650 at both the 20 mcg/day and 40 mcg/day doses.
Chiasma, Inc., a U.S. late-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application (NDA) for the marketing and sale of octreotide capsules, an oral drug proposed for the maintenance therapy of adult patients with acromegaly.
Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing at MD&M West (Hall D, Booth# 1751) Dow CorningĀ® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components.
› Verified 9 days ago